Log In
Print
BCIQ
Print
Print this Print this
 

GI-6207

  Manage Alerts
Collapse Summary General Information
Company GlobeImmune Inc.
DescriptionWhole heat-killed recombinant Saccharomyces cerevisiae genetically modified (Tarmogen) to express carcinoembryonic antigen (CEA)
Molecular Target Carcinoembryonic antigen (CEA)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationThyroid cancer
Indication DetailsTreat medullary thyroid cancer (MTC); Treat metastatic medullary thyroid cancer (MTC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today